Saito, Yuki
Hamamoto, Yasuo
Hirata, Kenro
Yamasaki, Makoto
Watanabe, Masaya
Abe, Tetsuya
Tsubosa, Yasuhiro
Hamai, Yoichi
Murakami, Kentaro
Bamba, Takeo
Yoshii, Takako
Tsuda, Masahiro
Watanabe, Masayuki
Ueno, Masaki
Kitagawa, Yuko
Article History
Received: 5 January 2023
Accepted: 6 March 2023
First Online: 28 March 2023
Declarations
:
: This study was approved by the institutional ethics committee of Keio University Hospital. This study was conducted in accordance with the principles of the Declaration of Helsinki. The need of written informed consent was waived by the institutional ethics committee of Keio University Hospital, but patients could opt out of having their data collected.
: Not applicable.
: Yasuo Hamamoto reports funding from Ono Pharmaceutical Co., Ltd. outside the submitted work. Yuko Kitagawa reports personal fees from Nippon Kayaku Co., Ltd. and Bristol-Myers Squibb K.K., and grants from Yakult Honsha Co. Ltd., Kyouwa Hakkou Kirin Co., Ltd., Eisai Co., Ltd., and Takeda Pharmaceutical Co., Ltd., outside the submitted work. The other authors declare no conflicts of interest.